Cannabis
1933 Industries Receives Approval to Transfer its Cultivation Licenses and to Commence Cultivation Operations at its Newly Constructed Facility in Las Vegas
1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF), a vertically integrated cannabis consumer packaged goods company that owns licensed cultivation and manufacturing assets to support its brands, reports that it received both Clark County and Nevada Department of Taxation final approvals for the transfer of its existing cultivation licenses to its new cultivation facility, which completes all the necessary steps to begin the transfer of its cannabis plants.
Mr. Caleb Zobrist, Executive Vice President and Legal Counsel commented, “We have worked closely with county and state authorities to ensure the smooth transfer of our cultivation licenses from the old facility to the new one. Having the licenses in place enables us to commence cultivation operations in the new facility immediately.”
With all site work completed, the Company will begin the transfer of its cannabis plants, including 5,000 clones, and 200 moms to populate the new facility, with the aim of completing 2 full zones or six rooms within a week in its first phase. The clones will vegetate for about four weeks before beginning the flower cycle. “We will start acclimatizing the plants in the new rooms and ensure that all life-support systems, such as temperature, irrigation, light and humidity controls are functioning as designed,” said Mr. Tim Spencer, Director of Cultivation.
Once the new facility is fully operational and all systems are optimized, the Company expects to produce approximately 700-800 lbs. of dried cannabis per month, to be utilized for its AMA branded flower and concentrate products currently sold to licensed dispensaries throughout Nevada. AMA’s live resins and vape pens are the Company’s best selling items due to their versatility and contain cannabis-derived terpenes in a variety of flavours. The new facility will provide better control over the input material for its live resin products and use a flash freezing fresh flower process to preserve monoterpenes that are not found in cured biomass. This process allows the Company to extract a better representation of the full terpene profile of the flower for increased potency and better taste.
Mr. Spencer remarked, “Our 26 in-house plant varieties were carefully selected for their quality and terpene profiles. Our goal is to cultivate premium flower to produce the best concentrates in the Nevada market at reasonable prices. We are also excited to begin working with our world class breeder partner, OG DNA Genetics, as soon as we settle in our new facility.”
SOURCE 1933 Industries Inc.
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan6 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf6 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis6 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care